Who we are
PanKind, The Australian Pancreatic Cancer Foundation, is dedicated to dramatically increasing survival rates and quality of life for those impacted by pancreatic cancer.
We focus on raising awareness, providing patient support, and funding critical research to tackle this deadly disease, ensuring progress today and hope for the future.
Our patient-centred approach involves national collaboration with researchers, healthcare professionals, and key stakeholders to accelerate change. We're driving early detection efforts and advancing new treatments, aiming to give patients more options and better outcomes.
One of our flagship efforts is the Early Detection Initiative, which focuses on diagnosing pancreatic cancer earlier, improving survival chances. Through increased funding and clinical trials, we aim to bring life-saving treatments to patients faster, offering new hope to those affected.
About PanKind
The only charity in Australia exclusively dedicated to pancreatic cancer.
We have invested over $14 million across 66 high-calibre research projects at universities and institutions, funding some of Australia’s top research talent
Our independent Scientific Advisory Panel is made up of globally recognised scientific and medical experts who are responsible for assessing our research investments. Our research investment has been leveraged by grant recipients for an additional $10.1 million in funding
We have united over 40,000 people against the disease through nationwide community engagement events in 11 capital cities, increasing awareness, engagement and community support
Through our National Patient and Carer Support Hub we are connecting patients and carers to credible information, support, available trials, and pancreatic cancer experts across Australia
We launched a national awareness campaign with the Cancer of our Generation report, educating the Australian public on pancreatic cancer statistics, reaching almost 1 million Australians with key information.
We are the voice of the people, advocating for the best possible outcomes for pancreatic cancer patients and their families.
Click here to learn more about our work, please visit our website for more information.
